Standout Papers
- Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials (2023)
- Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials (2024)
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t (2017)
- Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation (2024)
Immediate Impact
62 standout
Citing Papers
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
2024 Standout
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
2024 Standout
Works of Bolanle Akinlade being referenced
Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study
2022
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bolanle Akinlade | 744 | 1068 | 871 | 44 | 1.7k | |
| Paolo Campi | 374 | 521 | 632 | 36 | 1.6k | |
| Ira Finegold | 1273 | 773 | 1578 | 41 | 2.1k | |
| Zelma C. Chiesa Fuxench | 657 | 1669 | 1227 | 71 | 2.2k | |
| E.A. Bingham | 386 | 1010 | 789 | 43 | 1.6k | |
| Grażyna Pulka | 469 | 752 | 556 | 33 | 1.2k | |
| Paul K. Keith | 1015 | 396 | 978 | 70 | 2.0k | |
| Anna Nopp | 723 | 499 | 1444 | 57 | 1.8k | |
| Nikhil Amin | 991 | 248 | 868 | 56 | 1.6k | |
| Anne Braae Olesen | 313 | 997 | 389 | 53 | 1.8k | |
| Patrizia Bonadonna | 289 | 556 | 1109 | 65 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...